EMA
approval
· 2025-06-12
EMA Authorised: Nyxoid (naloxone hydrochloride dihydrate) — Mundipharma Corporation (Ireland) Limited
Summary
EMA has authorised Nyxoid (naloxone hydrochloride dihydrate) for the emergency treatment of opioid overdose. The product is manufactured by Mundipharma Corporat…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Status: Authorised. Therapeutic area: Opiate Overdose. MAH: Mundipharma Corporation (Ireland) Limited. Decision date: 25/04/2025